Transplantation and Cellular Therapy Program

The Transplantation and Cellular Therapy Research Program has 41 members representing five departments and three schools within the Academic Health Center at the University of Minnesota.

Members of this program seek to reduce or eliminate factors limiting hematopoietic stem cell transplantation, such as regimen-related toxicities, graft-versus-host disease (GVHD), and delayed reconstitution of immunity. These scientific goals are accomplished through the development of novel treatment strategies from preclinical studies to early clinical testing in the following themes:

  • Hematopoietic reconstitution
  • Immunological reconstitution - GVHD prevention and treatment
  • Immunological reconstitution - Thymus
  • Relapse prevention and treatment

Go to Umbilical Cord Blood Transplantation >

Program Leader

John Wagner

John Wagner, MD
Professor, Department of Pediatrics